Spots Global Cancer Trial Database for advanced pancreatic adenocarcinoma

Every month we try and update this database with for advanced pancreatic adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Combining Epigenetic And Immune Therapy to Beat Cancer.	NCT04705818	Advanced Solid ... Advanced Colore... Advanced Soft-t... Advanced Pancre... Adult Solid Tum...	Durvalumab Tazemetostat	18 Years -	Institut Bergonié
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer	NCT04634539	Advanced Pancre... Pancreatic Canc... Pancreatic Duct...	Gemcitabine Nab-paclitaxel L-glutamine	18 Years -	Cedars-Sinai Medical Center
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma	NCT03717298	Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise...	Ocoxin-Viusid®	18 Years -	Catalysis SL
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors	NCT04616534	Advanced Fallop... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Primar... Fallopian Tube ... Metastatic Panc... Ovarian High Gr... Platinum-Resist... Platinum-Resist... Platinum-Resist... Primary Periton... Stage II Pancre... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Pa...	Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Gemcitabine	18 Years -	National Cancer Institute (NCI)
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors	NCT04616534	Advanced Fallop... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Primar... Fallopian Tube ... Metastatic Panc... Ovarian High Gr... Platinum-Resist... Platinum-Resist... Platinum-Resist... Primary Periton... Stage II Pancre... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Pa...	Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Gemcitabine	18 Years -	National Cancer Institute (NCI)
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma	NCT03717298	Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise...	Ocoxin-Viusid®	18 Years -	Catalysis SL
ZN-c3 + Gemcitabine in Pancreatic Cancer	NCT06015659	Advanced Pancre... Pancreatic Canc... Pancreatic Duct...	Zentalis Gemzar	18 Years -	Dana-Farber Cancer Institute
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors	NCT04616534	Advanced Fallop... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Primar... Fallopian Tube ... Metastatic Panc... Ovarian High Gr... Platinum-Resist... Platinum-Resist... Platinum-Resist... Primary Periton... Stage II Pancre... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Pa...	Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Gemcitabine	18 Years -	National Cancer Institute (NCI)
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer	NCT04524702	Advanced Pancre... Metastatic Panc... Stage IV Pancre...	Gemcitabine Hydroxychloroqu... Nab-paclitaxel Paricalcitol	18 Years -	Emory University
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer	NCT04789486	Non-small Cell ... Advanced Pancre... Unresectable Pa... Ductal Adenocar...	AGuIX Radiotherapy	18 Years -	Dana-Farber Cancer Institute
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer	NCT04634539	Advanced Pancre... Pancreatic Canc... Pancreatic Duct...	Gemcitabine Nab-paclitaxel L-glutamine	18 Years -	Cedars-Sinai Medical Center
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer	NCT06266143	Advanced Pancre...	Y101D	18 Years - 75 Years	Wuhan YZY Biopharma Co., Ltd.
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer	NCT04634539	Advanced Pancre... Pancreatic Canc... Pancreatic Duct...	Gemcitabine Nab-paclitaxel L-glutamine	18 Years -	Cedars-Sinai Medical Center
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer	NCT06266143	Advanced Pancre...	Y101D	18 Years - 75 Years	Wuhan YZY Biopharma Co., Ltd.
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer	NCT04789486	Non-small Cell ... Advanced Pancre... Unresectable Pa... Ductal Adenocar...	AGuIX Radiotherapy	18 Years -	Dana-Farber Cancer Institute

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: